The proposed acquisition offers Option Care Health shareholders a substantial cash premium, and gives McKesson a strategic foothold in delivering complex therapies closer to patients.
McKesson Corporation (NYSE: MCK) and private investment firm Clayton, Dubilier & Rice are making a $5.8 billion…